產(chǎn)品中心
產(chǎn)品詳情

  • 產(chǎn)品名稱：VWA5A抗原（重組蛋白）

  • 產(chǎn)品型號：100ug
  • 產(chǎn)品廠商：通蔚生物
  • 產(chǎn)品價格：800
  • 產(chǎn)品庫存：35
  • 產(chǎn)品文檔：
你添加了1件商品 查看購物車
簡單介紹：
我司 VWA5A抗原（重組蛋白）提供多達兩萬種產(chǎn)品，大部分現(xiàn)貨銷售，客戶關系管理系統(tǒng)和客戶關系管理團隊，能**時間響應售前、售后需求，關注客戶體驗及滿意度。為您提供專業(yè)、耐心的服務，歡迎廣大用戶來電來涵咨詢購買。
詳情介紹：

中文名稱： VWA5A抗原（重組蛋白）

英文名稱： VWA5A Antigen (Recombinant Protein)

別     名：  BCSC1; BCSC-1; LOH11CR2A

儲     存：  冷凍（-20℃）

相關類別： 抗原

概     述：

Fusion protein corresponding to C terminal 250 amino acids of human VWA5A

技術規(guī)格

Full name:

von Willebrand factor A domain containing 5A

Synonyms:

BCSC1; BCSC-1; LOH11CR2A

Swissprot:

O00534

Gene Accession:

BC001234

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

VWA5A (von Willebrand factor A domain containing 5A), also known as BCSC-1 (breast cancer suppressor candidate 1) or LOH11CR2A (loss of heterozygosity 11 chromosomal region 2 gene A protein), is a 786 amino acid protein containing one VIT domain and one VWFA domain. VWA5A is expressed at low levels in various tissues, with no expression found in 80% of tumor cell lines. Likely acting as a tumor suppressor gene, deletion of VWA5A leads to loss of heterozygosity (LOH) in breast and ovarian tumors, and may have an important role as a potential gene therapy target. Abnormal expression of VWA5A may lead to an increase in adhesion of CNE-2L2 cells associated with an increase in expression of E-cadherin, alpha-catenin, and p53, resulting in a decrease of malignant activity in cells with ectopic expression of VWA5A.





姓名：
電話：
您的需求：